Resveratrol-Activated AMPK/SIRT1/Autophagy in Cellular Models of Parkinson’s Disease
Yun‐Cheng Wu(Shanghai Jiao Tong University), Tianhong Pan(Anhui University)
Cited by 478
Related Papers
A 36-week multicenter, randomized, double-blind, placebo-controlled, parallel-group, phase 3 clinical trial of sodium oligomannate for mild-to-moderate Alzheimer’s dementia
|Alzheimer s Research & Therapy|2021|200
The Critical Role of SIRT1 in Parkinson’s Disease: Mechanism and Therapeutic Considerations
|Aging and Disease|2020|128
Magnetofection based on superparamagnetic iron oxide nanoparticle-mediated low lncRNA HOTAIR expression decreases the proliferation and invasion of glioma stem cells
|International Journal of Oncology|2016|67